Phenytoin Sodium
- PHENYTOIN SODIUM
- 630-93-3
- 5,5-Diphenylhydantoin sodium salt
- Dilantin sodium
- Sodium phenytoin
- Create:2005-06-29
- Modify:2025-01-11
- 5,5-Diphenylhydantoin
- 5,5-diphenylimidazolidine-2,4-dione
- Antisacer
- Difenin
- Dihydan
- Dilantin
- Diphenylhydantoin
- Diphenylhydantoinate, Sodium
- Epamin
- Epanutin
- Fenitoin
- Hydantol
- Phenhydan
- Phenytoin
- Phenytoin Sodium
- Sodium Diphenylhydantoinate
- PHENYTOIN SODIUM
- 630-93-3
- 5,5-Diphenylhydantoin sodium salt
- Dilantin sodium
- Sodium phenytoin
- Tacosal
- Diphenylhydantoin Sodium
- Novodiphenyl
- Decatona
- Diphantoine
- Epdantoin
- Epileptin
- Fenidantoin
- Fenigramon
- Fenitron
- Fenytoin
- Hidantin
- Phenilep
- Aladdin
- Alepsin
- Cumatil
- Ditoin
- Ditomed
- Enkefal
- Episar
- Epsolin
- Eptolin
- Muldis
- Fenitoin sodium
- Hidantal sodium
- Lepitoin sodium
- Denyl sodium
- Phenytoin sodium salt
- Aleviatin sodium
- Diphenine sodium
- Epilantin-E
- Fenitoina Sodica
- Diphenylan sodium
- Soluble phenytoin
- Metinal Idantoina
- Di-len
- Dilantin Injection
- Dilantin Suspension
- Antisacer
- OM-Hydantoine sodium
- PHENYTEK
- SDPH
- Sodium diphenylhydantoin
- Diphentoin
- Epanutin
- Solantoin
- Solantyl
- Eptoin
- Sodium diphenyl hydantoinate
- Sodium 5,5-diphenylhydantoinate
- Sodium 5,5-diphenyl hydantoinate
- sodium 2,5-dioxo-4,4-diphenylimidazolidin-1-ide
- 5,5-Diphenylhydantoin sodium
- EINECS 211-148-2
- MFCD00069674
- Hydantoin, 5,5-diphenyl-, sodium salt
- UNII-4182431BJH
- Sodium 5,5-diphenyl-2,4-imidazolidinedione
- 4182431BJH
- Phenytoin sodium [USP:JAN]
- 2,4-Imidazolidinedione, 5,5-diphenyl-, monosodium salt
- Hydantoin, 5,5-diphenyl-, monosodium salt
- MLS000554076
- DTXSID2023775
- NSC 757274
- PHENYTOIN SODIUM, PROMPT
- Citrullamon
- Dihydan
- SMR000146393
- Dilantin Infatabs
- NSC-757274
- Phenytoin sodium,prompt
- Phenytoin sodium (USP:JAN)
- Phenytoin sodium extended
- Phenytoin sodium,extended
- PHENYTOIN SODIUM (MART.)
- PHENYTOIN SODIUM [MART.]
- PHENYTOIN SODIUM (USP-RS)
- PHENYTOIN SODIUM [USP-RS]
- Prompt Phenytoin Sodium
- sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione
- MLS000028562
- PHENYTOIN SODIUM (EP IMPURITY)
- PHENYTOIN SODIUM [EP IMPURITY]
- PHENYTOIN SODIUM (EP MONOGRAPH)
- PHENYTOIN SODIUM [EP MONOGRAPH]
- PHENYTOIN SODIUM (USP MONOGRAPH)
- PHENYTOIN SODIUM [USP MONOGRAPH]
- Diphenylhydantoin sodium salt
- PHENYTOIN SODIUM, EXTENDED
- Phenytoin, sodium salt
- Extended Phenytoin Sodium
- SMR000058987
- fenitoinsodium
- Sodium 5,5-Diphenylhydantoin
- Diphenylhydantoin, sodium salt
- PHENYTOINER
- Diphenylhydantoin (Phenytoin), sodium salt
- Opera_ID_1233
- Diphenylhydantoinate, Sodium
- SPECTRUM1500485
- 5,5-Diphenyl-2,4-imidazolidinedione, monosodium salt
- DTXCID803775
- SCHEMBL3051683
- PHENYTOIN SODIUM [VANDF]
- HMS501J09
- 5,5-Diphenylhydatoin sodium salt
- PHENYTOIN SODIUM [WHO-DD]
- PHENYTOIN SODIUM [WHO-IP]
- HMS1920H10
- HMS2091P14
- HMS2233K24
- HMS3259H11
- HMS3373O11
- PHENYTOIN SODIUM SALT [MI]
- Tox21_302338
- CCG-39219
- AKOS003273947
- AKOS015951389
- AKOS025310163
- PHENYTOIN SODIUM [ORANGE BOOK]
- NC00642
- PHENYTOIN SODIUM,PROMPT [VANDF]
- NCGC00094758-01
- NCGC00094758-02
- NCGC00164434-01
- NCGC00255285-01
- PHENYTOIN SODIUM EXTENDED [VANDF]
- PHENYTOIN SODIUM,EXTENDED [VANDF]
- AS-13308
- CAS-630-93-3
- 5,5-Diphenylhydantoin sodium salt, >=99%
- PHENYTOINUM NATRICUM [WHO-IP LATIN]
- D1331
- DIPHENYLHYDANTOIN SODIUM [GREEN BOOK]
- PHENYTOIN SODIUM FOR INJECTION [JAN]
- H12023
- SR-05000001698
- Q-201564
- SR-05000001698-1
- Q27258415
- 2,4-Imidazolidinedione, 5,5-diphenyl-, sodium salt (1:1)
- Phenytoin sodium, European Pharmacopoeia (EP) Reference Standard
- Phenytoin sodium, United States Pharmacopeia (USP) Reference Standard
- Phenytoin sodium, Pharmaceutical Secondary Standard; Certified Reference Material
H301 (18.8%): Toxic if swallowed [Danger Acute toxicity, oral]
H302 (81.2%): Harmful if swallowed [Warning Acute toxicity, oral]
H317 (82.8%): May cause an allergic skin reaction [Warning Sensitization, Skin]
H351 (78.1%): Suspected of causing cancer [Warning Carcinogenicity]
H360 (15.6%): May damage fertility or the unborn child [Danger Reproductive toxicity]
H361 (83.3%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
H372 (18.2%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]
P203, P260, P261, P264, P270, P272, P280, P301+P316, P301+P317, P302+P352, P318, P319, P321, P330, P333+P317, P362+P364, P405, and P501
(The corresponding statement to each P-code can be found at the GHS Classification page.)
Aggregated GHS information provided per 192 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
Acute Tox. 3 (18.8%)
Acute Tox. 4 (81.2%)
Skin Sens. 1 (82.8%)
Carc. 2 (78.1%)
Repr. 1B (15.6%)
Repr. 2 (83.3%)
STOT RE 1 (18.2%)
Hazard Traits - Carcinogenicity
Authoritative List - NTP RoC - reasonable; Prop 65
Report - regardless of intended function of ingredient in the product
IMAP assessments - 2,4-Imidazolidinedione, 5,5-diphenyl-, monosodium salt: Human health tier I assessment
IMAP assessments - 2,4-Imidazolidinedione, 5,5-diphenyl-, monosodium salt: Environment tier I assessment
- Australian Industrial Chemicals Introduction Scheme (AICIS)2,4-Imidazolidinedione, 5,5-diphenyl-, monosodium salthttps://services.industrialchemicals.gov.au/search-assessments/
- ChemIDplusPhenytoin sodium [USP:JAN]https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000630933ChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- EPA Chemicals under the TSCA2,4-Imidazolidinedione, 5,5-diphenyl-, sodium salt (1:1)https://www.epa.gov/chemicals-under-tscaEPA TSCA Classificationhttps://www.epa.gov/tsca-inventory
- EPA DSSToxDiphenylhydantoin sodiumhttps://comptox.epa.gov/dashboard/DTXSID2023775CompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-noticePhenytoin sodiumhttps://chem.echa.europa.eu/100.010.136Phenytoin sodium (EC: 211-148-2)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/39248
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingPHENYTOIN SODIUMhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/4182431BJH
- New Zealand Environmental Protection Authority (EPA)LICENSEThis work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International licence.https://www.epa.govt.nz/about-this-site/general-copyright-statement/
- California Office of Environmental Health Hazard Assessment (OEHHA)Diphenylhydantoin (Phenytoin), Sodium Salthttps://oehha.ca.gov/proposition-65/chemicals/diphenylhydantoin-phenytoin-sodium-salt
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseNCI Thesaurushttps://ncit.nci.nih.gov
- California Safe Cosmetics Program (CSCP) Product DatabaseDiphenylhydantoin (Phenytoin), sodium salthttps://www.cdph.ca.gov/Programs/CCDPHP/DEODC/OHB/CSCP/Pages/About-CSCP.aspx
- CCSbaseCCSbase Classificationhttps://ccsbase.net/
- ClinicalTrials.govLICENSEThe ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use
- DailyMedEXTENDED PHENYTOIN SODIUMhttps://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=EXTENDED+PHENYTOIN+SODIUM
- Drug Gene Interaction database (DGIdb)LICENSEThe data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.http://www.dgidb.org/downloadsPHENYTOIN SODIUMhttps://www.dgidb.org/drugs/rxcui:71227
- Drugs@FDALICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingPHENYTOIN SODIUMhttps://www.accessdata.fda.gov/scripts/cder/daf/
- EU Clinical Trials Register
- FDA Approved Animal Drug Products (Green Book)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- FDA Orange BookLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- FDA Medication GuidesLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingDILANTINhttps://dps.fda.gov/medguide
- KEGGLICENSEAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial licensehttps://www.kegg.jp/kegg/legal.html
- National Drug Code (NDC) DirectoryLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingEXTENDED PHENYTOIN SODIUMhttps://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
- NLM RxNorm TerminologyLICENSEThe RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.htmlphenytoin sodiumhttps://rxnav.nlm.nih.gov/id/rxnorm/71227
- SpectraBasePhenytoin sodiumhttps://spectrabase.com/spectrum/HxHzZ3Mogrc
- Springer Nature
- Thieme ChemistryLICENSEThe Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc-nd/4.0/
- Wikidataphenytoin sodiumhttps://www.wikidata.org/wiki/Q27258415
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.htmlAnticonvulsantshttps://www.ncbi.nlm.nih.gov/mesh/68000927Cytochrome P-450 CYP1A2 Inducershttps://www.ncbi.nlm.nih.gov/mesh/68065694Voltage-Gated Sodium Channel Blockershttps://www.ncbi.nlm.nih.gov/mesh/68061567
- PubChem
- GHS Classification (UNECE)GHS Classification Treehttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
- EPA Substance Registry ServicesEPA SRS List Classificationhttps://sor.epa.gov/sor_internet/registry/substreg/LandingPage.do
- NCBI